# Extension Study on Safety and Rebound Effect of SAT-001 for Myopia in Children

> **NCT06742268** · — · RECRUITING · sponsor: **S-Alpha Therapeutics, Inc.** · enrollment: 40 (estimated)

## Conditions studied

- Myopia

## Interventions

- **OTHER:** Single vision spectacles

## Key facts

- **NCT ID:** NCT06742268
- **Lead sponsor:** S-Alpha Therapeutics, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2024-12-16
- **Primary completion:** 2025-10-30
- **Final completion:** 2026-07-30
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2025-01-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06742268

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06742268, "Extension Study on Safety and Rebound Effect of SAT-001 for Myopia in Children". Retrieved via AI Analytics 2026-07-05 from https://api.ai-analytics.org/clinical/NCT06742268. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*